Monday, 5 September 2016

Fanatrex



gabapentin

Dosage Form: oral suspension - kit
Fanatrex

Fanatrex Description


NDC 43093-105-01


Rx only


FusePaq™


Fanatrex™


(gabapentin 25 mg/mL, in oral suspension - kit)



FusePaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).



Description:



This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin.  This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.



Contents:


  • 10.5 g gabapentin, USP

  • 420 mL oral suspension vehicle (water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, sodium benzoate, potassium sorbate, dibasic sodium phosphate)

  • Disposable funnel

  • Press-in bottle adaptor for oral dispenser

  • Oral dispenser

  • Instructions


SUGGESTED PREPARATION


Suggested Preparation

Gabapentin, 25 mg/mL oral suspension




1    Remove and Inspect the Contents of the Kit


Remove kit contents. Ensure that seals are present and intact on the gabapentin and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.




2    Prepare for Mixing


Wear gloves and eye protection during mixing operations. Remove the seal from the oral suspension bottle. Break the seal and remove the cap from the gabapentin bottle.




3    Transfer Gabapentin to the Suspension Bottle


Uncap the suspension bottle. Using the included funnel, carefully transfer the gabapentin powder to the suspension bottle. Cap the suspension bottle and mix thoroughly by inverting and shaking until all contents are dissolved. Uncap the suspension bottle. Pour a small amount of the mixed suspension back into the gabapentin bottle. Cap the gabapentin bottle and shake to ensure that all residual gabapentin has been dissolved. Pour the liquid through the funnel into the suspension bottle. Discard the funnel and gabapentin powder bottle.




4    Complete the Mixing Process


Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times. Visually ensure that all contents are dissolved.




5    Re-label the Suspension


Label the mixed suspension as required for prescription products. Ensure that the original oral suspension vehicle label is removed or obscured, since the original label is no longer accurate once the suspension is prepared.




Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the mixed suspension between 15-30°C (59-86°F). The mixed suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies.


Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test <61>. In addition, the suspension vehicle formulation has passed the USP <51> Antimicrobial Effectiveness Test.


An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.




U.S. Patents Pending




Manufactured by:

Fusion Pharmaceuticals, LLC

768 Calle Plano

Camarillo, CA 93012



CS75-A1 rev 0



DRUG BOTTLE LABEL


Do not use if safety seal is broken


Gabapentin

1-(Aminomethyl)cyclohexaneacetic acid

CAS #60142-96-3

CAUTION: For manufacturing, processing, repacking, or prescription compounding


Net contents: 10.5 g


Repackaged by Fusion Pharmaceuticals, LLC

Camarillo, CA 93012


CS73-A1 rev 0




SUSPENSION BOTTLE LABEL


Do not use if safety seal is broken

For Prescription Compounding Only


Oral Suspension Vehicle

Dye and paraben free


Ingredients: water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate


Net Contents: 420 mL (14.2 fl oz)


Manufactured for:

Fusion Pharmaceuticals, LLC

Camarillo, CA 93012


CS74-A1 rev 0




Carton Box Label


Do not use if safety seal is broken


NDC 43093-105-01


Rx only


FusePaq™  Kit for Oral Suspension

Fanatrex™

(gabapentin 25 mg/mL, in oral suspension - kit)



Description:

This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin. This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.


Active Ingredient:


  • 10.5 g gabapentin, USP



Inactive Ingredients:


  • 420 mL oral suspension vehicle (water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate)

  • Disposable funnel

  • Press-in bottle adaptor for oral dispenser

  • Oral dispenser

  • Instructions



CAUTION: For manufacturing, processing, repacking, or presciption compounding. Federal law prohibits dispensing without prescription.


U.S. Patents Pending


CS72-A1 rev 0

























Fanatrex 
gabapentin  kit






Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)43093-105










Packaging
#NDCPackage DescriptionMultilevel Packaging
143093-105-011 KIT In 1 KITNone











QUANTITY OF PARTS
Part #Package QuantityTotal Product Quantity
Part 11 BOTTLE, GLASS  10.5 g
Part 21 BOTTLE, PLASTIC  420 mL



Part 1 of 2
GABAPENTIN 
gabapentin  powder, for suspension










Product Information
   
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Gabapentin (Gabapentin)Gabapentin10.5 g  in 10.5 g





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
110.5 g In 1 BOTTLE, GLASSNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2010




Part 2 of 2
ORAL SUSPENSION VEHICLE 
suspension  liquid










Product Information
   
Route of AdministrationORALDEA Schedule    






Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
No Active Ingredients Found
































Inactive Ingredients
Ingredient NameStrength
Water 
Banana 
N-Acetylglucosamine 
Strawberry 
ALTHAEA OFFICINALIS LEAF 
Glycerin 
Stevia Leaf 
Acesulfame Potassium 
Xanthan Gum 
GLYCYRRHIZIN, AMMONIATED 
Saccharin Sodium 
Potassium Sorbate 
Sodium Benzoate 
Sodium Phosphate, Dibasic 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
1420 mL In 1 BOTTLE, PLASTICNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2010











Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2010


Labeler - Fusion Pharmaceuticals LLC (021420944)









Establishment
NameAddressID/FEIOperations
Fusion Pharmaceuticals LLC021420944manufacture
Revised: 05/2010Fusion Pharmaceuticals LLC




More Fanatrex resources


  • Fanatrex Side Effects (in more detail)
  • Fanatrex Use in Pregnancy & Breastfeeding
  • Fanatrex Drug Interactions
  • Fanatrex Support Group
  • 0 Reviews for Fanatrex - Add your own review/rating


Compare Fanatrex with other medications


  • Alcohol Withdrawal
  • Anxiety
  • Benign Essential Tremor
  • Bipolar Disorder
  • Burning Mouth Syndrome
  • Diabetic Nerve Damage
  • Epilepsy
  • Erythromelalgia
  • Fibromyalgia
  • Hiccups
  • Hot Flashes
  • Hyperhidrosis
  • Insomnia
  • Migraine
  • Nausea/Vomiting, Chemotherapy Induced
  • Pain
  • Periodic Limb Movement Disorder
  • Peripheral Neuropathy
  • Persisting Pain, Shingles
  • Postmenopausal Symptoms
  • Pruritus
  • Reflex Sympathetic Dystrophy Syndrome
  • Restless Legs Syndrome
  • Trigeminal Neuralgia
  • Vulvodynia

No comments:

Post a Comment